REPORT ON THE USE OF SUCCINYL CHOLINE DICHLORIDE (A CURARE-LIKE DRUG) IN ELECTROCONVULSIVE THERAPY
Abstract
Succinyl choline dichloride i.v. is a useful drug to produce muscular relaxation in patients receiving ECT who would otherwise be poor risks because of susceptibility to fractures and pre-existing fractures. It has also proved of value in treating severely disabled cardiac patients for whom even slight exertion may be dangerous. This drug is potent and effective, but ultra-short-acting, seldom lasting more than 5 minutes. Artificial respiration is easily and adequately performed by standard routine methods. Oxygenation can be maintained at levels superior to that of bed rest. No untoward effects have yet been observed in over 300 electric treatments.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
